Chlordiazepoxide-induced discrimination impairment

Area of Science:

• Neuroscience
• Behavioral Pharmacology
• Cognitive Science

Background:

• Benzodiazepines, like chlordiazepoxide, are known for their anxiolytic and sedative effects.
• Understanding the specific cognitive effects of benzodiazepines is crucial for their clinical application and for elucidating neural mechanisms of cognition.

Purpose of the Study:

• To investigate the effects of chlordiazepoxide on reinforcement-cued discrimination performance in rats.
• To analyze the specific behavioral components contributing to any observed performance deficits.

Main Methods:

• Male Sprague-Dawley rats were administered chlordiazepoxide (2.5, 5.0, or 10.0 mg/kg) or saline over 10 successive sessions.
• Performance was assessed in a reinforcement-cued discrimination task.
• Response components during 'go' and 'no-go' phases were analyzed during post-drug recovery sessions.

Main Results:

• Chlordiazepoxide at 5.0 and 10.0 mg/kg significantly impaired discrimination performance.
• No significant impairment was observed at the 2.5 mg/kg dose.
• Impairment was primarily attributed to reduced inhibition of responding during 'no-go' phases.
• Good recovery of performance was noted during three post-drug saline sessions.

Conclusions:

• Chlordiazepoxide impairs a specific aspect of cognitive control, namely response inhibition, in a dose-dependent manner.
• The observed deficits are reversible upon cessation of the drug.
• These findings contribute to understanding the behavioral pharmacology of benzodiazepines and their impact on executive functions.